CBD of Denver signs definitive deal to acquire Greece's BioCannabis in stock swap
What's the deal? CBD of DenverDealroom has a profile for this one. Try Dealroom → (OTCID: CBDD) has signed a definitive share exchange agreement to acquire BioCannabis M. IKEDealroom has a profile for this one. Try Dealroom →, a Greece-based health and wellness company. CBDD will acquire BioCannabis in exchange for its own shares, with the value undisclosed. The deal is subject to customary closing conditions and regulatory approvals.
Why now? The agreement follows a previously announced letter of intent and the completion of CBDD's due diligence review. Management called it "an important step in the Company's transformation" toward the health and wellness sector.
What's the endgame? CBDD, a publicly traded company, has pursued a strategy of identifying operating businesses it believes can deliver sustainable operations. It expects BioCannabis to provide a foundation for new products, market expansion, and future strategic opportunities.
What could go wrong? The transaction still requires corporate and regulatory approvals before closing. Terms and the anticipated corporate structure have not been disclosed, and CBDD says further details will follow in subsequent filings.
"The Share Exchange Agreement follows a thorough diligence process and moves us decisively toward closing," said Alexandre Nikulin, chief executive officer of CBD of Denver. He added that BioCannabis and the broader wellness sector "provide an attractive foundation for the next stage of CBDD's development."
The signal: The deal ties a US-listed shell-style vehicle to a European operating base in a fast-growing market. The Global Wellness InstituteDealroom has a profile for this one. Try Dealroom → pegged the worldwide wellness economy at roughly $6.8 trillion in 2024, with projected growth to about $9.8 trillion by 2029 — the backdrop CBDD is betting on to reposition itself.
Read more: finanznachrichten.de
Image credit: Generated with Gemini
